Clinical Trial Update: Oral Baricitinib (LY3009104)Treatment in Japanese Participants With Active Rheumatoid Arthritis on Background Methotrexate Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of oral baricitinib (LY3009104) in Japanese patients with active rheumatoid arthritis on background methotrexate therapy; results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED | Results posted: 2018-11-01